These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24025726)

  • 21. Changes in gene expression variability reveal a stable synthetic lethal interaction network in BRCA2-ovarian cancers.
    Bueno R; Mar JC
    Methods; 2017 Dec; 131():74-82. PubMed ID: 28754563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
    Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
    Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic lethal screens as a means to understand and treat MYC-driven cancers.
    Cermelli S; Jang IS; Bernard B; Grandori C
    Cold Spring Harb Perspect Med; 2014 Mar; 4(3):. PubMed ID: 24591535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
    Godwin TD; Kelly ST; Brew TP; Bougen-Zhukov NM; Single AB; Chen A; Stylianou CE; Harris LD; Currie SK; Telford BJ; Beetham HG; Evans GB; Black MA; Guilford PJ
    Gastric Cancer; 2019 Mar; 22(2):273-286. PubMed ID: 30066183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Silico Inference of Synthetic Cytotoxic Interactions from Paclitaxel Responses.
    Lee JH; Lee KH; Kim JH
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Pan-Cancer Review of ALK Mutations: Implications for Carcinogenesis and Therapy.
    Yau NK; Fong AY; Leung HF; Verhoeft KR; Lim QY; Lam WY; Wong IC; Lui VW
    Curr Cancer Drug Targets; 2015; 15(4):327-36. PubMed ID: 25714698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
    Song J; Yu J; Jeong LS; Lee SK
    Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells.
    Molenaar JJ; Ebus ME; Geerts D; Koster J; Lamers F; Valentijn LJ; Westerhout EM; Versteeg R; Caron HN
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12968-73. PubMed ID: 19525400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
    Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
    FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-cancer activity of a novel small molecule compound that simultaneously activates p53 and inhibits NF-κB signaling.
    Hwang SG; Park J; Park JY; Park CH; Lee KH; Cho JW; Hwang JI; Seong JY
    PLoS One; 2012; 7(9):e44259. PubMed ID: 23028510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
    Srihari S; Singla J; Wong L; Ragan MA
    Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
    Gadhikar MA; Sciuto MR; Alves MV; Pickering CR; Osman AA; Neskey DM; Zhao M; Fitzgerald AL; Myers JN; Frederick MJ
    Mol Cancer Ther; 2013 Sep; 12(9):1860-73. PubMed ID: 23839309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
    Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
    Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal-Oriented Pathway Analyses Reveal a Signaling Complex as a Synthetic Lethal Target for p53 Mutations.
    Lu S; Cai C; Yan G; Zhou Z; Wan Y; Chen V; Chen L; Cooper GF; Obeid LM; Hannun YA; Lee AV; Lu X
    Cancer Res; 2016 Dec; 76(23):6785-6794. PubMed ID: 27758891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinase requirements in human cells: V. Synthetic lethal interactions between p53 and the protein kinases SGK2 and PAK3.
    Baldwin A; Grueneberg DA; Hellner K; Sawyer J; Grace M; Li W; Harlow E; Munger K
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12463-8. PubMed ID: 20616055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment and characterization of six human lung cancer cell lines: EGFR, p53 gene mutations and expressions of drug sensitivity genes.
    Ku JL; Kim KH; Choi JS; Jeon YK; Kim SH; Shin YK; Kim TY; Bang YJ; Kim WH; Park JG
    Cell Oncol (Dordr); 2011 Feb; 34(1):45-54. PubMed ID: 21290211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated High Throughput Analysis Identifies GSK3 as a Crucial Determinant of p53-Mediated Apoptosis in Lung Cancer Cells.
    Zhang Y; Zhu C; Sun B; Lv J; Liu Z; Liu S; Li H
    Cell Physiol Biochem; 2017; 42(3):1177-1191. PubMed ID: 28662516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis.
    Guo L; Li S; Qian B; Wang Y; Duan R; Jiang W; Kang Y; Dou Y; Yang G; Shen L; Wang J; Liang T
    Comput Struct Biotechnol J; 2020; 18():3243-3254. PubMed ID: 33240468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of p53 target database via integration of microarray and global p53 DNA-binding site analysis.
    Liu S; Mirza A; Wang L
    Methods Mol Biol; 2004; 281():33-54. PubMed ID: 15220520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.